Angela Watson

Doctor of Medicine,  The Johns Hopkins Hospital 

Location: United States

Consulting Services

Sales and Marketing Hospital-Pharmacy-Insurance Legal Support Case Consulting

Areas Of Interest

Clinical Trials, Phase 4 as Topic Vocabulary Tests Encystation, Parasite MTS1 Gene Aortic Stenosis, Subvalvular MVE 5 Tarsal Coalition Amylo 1,6 Glucosidase Deficiency Amino Acid Transporter Organizations, Non-Governmental Familial alpha Lipoprotein Deficiency Disease Count, Blood Cell Bridged-Ring Heterocyclic Compounds Preconception Injuries Ophthalmologist Synthase, FAS-II Cortex Primary, Visual P450 CYP1A2 Inducers Region, Genetic Terminator Self-Recorded Health Data Statistical Distributions Test Score, Educational Dipeptidyl-Peptidase IV Inhibitors Package Insert, Drug B-raf, Proto-Oncogene Proteins Dissection, Vertebral Artery Chronic Alcoholic Hepatitis

Professional Narrative

Dr. Angela Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Mayo Clinic 1992
Director Medicine, Mayo Clinic 2008

Education

Doctor of osteopathic medicine, Baylor College 2000
Bachelor of science in nursing, Yale School of Medicine 1992

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :